Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-19

Clinical Trial Update: Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a vaccine therapy in epithelial ovarian, fallopian tube, or peritoneal cancer has completed recruitment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-19